Search

everythinglearnresearchcommunity

for

Search:↓

Using cidofovir cream for a rare skin disease can cause skin darkening.

Niacinamide does not promote hair growth.

Minoxidil works faster, but ketoconazole is a safer alternative for female hair loss.

A specific enzyme that activates the hair growth medication minoxidil when applied to the skin was identified.

A woman's use of minoxidil for hair loss caused fluid buildup in her chest, which went away when she stopped using the product.

Topical valproate can effectively promote hair growth.

Lipid nanoparticles improve drug delivery through the skin, offering stability, controlled release, and better compatibility with skin.

JetPeel-assisted minoxidil improves hair density and thickness more than minoxidil alone.

Topical cetirizine 1% increases hair density and may be a promising treatment for hair loss.

Bimatoprost solution 0.03% is effective for treating sparse eyelashes.

Using too much minoxidil foam can cause a rare movement disorder with facial twitching, but symptoms go away when the correct dose is used.

A natural extract-based hair growth product was developed and showed promise in preliminary tests.

Topical scalp treatments could potentially reduce hair extraction.

Topical spironolactone effectively treats hair loss in women.

Minoxidil can help regrow hair or slow down hair loss, but results vary among individuals.

Lotions release minoxidil better than creams, with a recommended mix of propylene glycol, water, and ethanol improving effectiveness.

Minoxidil solution helps regrow hair in men with hair loss, with most improvement seen at 12 months and effects lasting over 30 months.

Epilation and DHT cause skin calcification by increasing ATP and calcium deposits.

Topical rosuvastatin and melatonin creams significantly reduce psoriasis severity and are safe.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Fractional CO2 laser with topical triamcinolone is more effective and safer for treating alopecia areata than intralesional triamcinolone.

Topical calcineurin inhibitors might be safer than steroids for scarring alopecia, but more research is needed.

Minoxidil is more effective than Latanoprost for treating patchy alopecia areata.

Spironolactone may help improve symptoms and tear quality in dry eye disease.

Topical prostaglandin analogs may help with hair growth but more research is needed.

Minoxidil can cause a skin reaction called ALEP.

Patients generally have positive attitudes towards using topical Minoxidil for hair loss treatment.

Using both 5% spironolactone and 5% minoxidil together is safe and more effective for treating hair loss.

Transethosomes improve drug delivery through the skin by overcoming the outer skin layer's barrier.

Topical minoxidil can rarely cause pleural effusion if ingested.